Diary: October 2008
NICE expects to consult on the following documents between 24 September and 21 October:
Draft scopes:
- Chronic obstructive pulmonary disorder (update) (22 September to 20 October 2008)
- Contraceptive services for socially disadvantaged young people (13 October to 10 November 2008)
- Heart failure (update) (13 October to 14 November 2008)
Draft consultation:
- Crohn´s disease - infliximab and adalimumab (17 September to 3 October 2008)
- Influenza (treatment) zanamivir, amantadine and oseltamivir (17 September to 3 October 2008)
- Thoracoscopic epicardial radiofrequency ablation for atrial fibrillation (23 September to 21 October 2008)
- Tenotomy of four horizontal eye muscles for nystagmus (23 September to 21 October 2008)
- Schizophrenia (update) (23 September to 17 November 2008)
- Low back pain (1 October to 26 November 2008)
- Glaucoma (2 October to 28 November 2008)
- Diarrhoea and vomiting in children (7 October to 1 December 2008
- Diabetes Type 2 (new drugs) update (8 October to 5 November 2008)
Other guidance development milestones between 24 September and 21 October:
Call for stakeholder registration:
- None
Stakeholder meetings:
- Excessive weight gain in pregnancy (8 October 2008)
- School-based interventions to prevent smoking (3 October 2008)
- Chronic Obstructive Pulmonary Disorder (update) (15 October 2008)
- Heart failure (update) (10 November 2008)
Final scopes:
Final consultation:
- Lung cancer (non-small cell) - erlotinib (26 September to 10 October 2008)
- Organ preservation (renal) - machine perfusion and static storage (1 to 30 September 2008)
Consultation on synopsis of evidence:
- Immunisation (24 September to 22 October 2008)
Appeals to be heard:
- Rheumatoid arthritis - adalimumab, etanercept and infliximab - sequential use (29 September 2008)
